Invo Bioscience Says On June 18, 2024, Co Received Notice From Nasdaq Informing Co Was Granted Request For Continued Listing On Nasdaq
Portfolio Pulse from Benzinga Newsdesk
Invo Bioscience announced that on June 18, 2024, it received a notice from Nasdaq granting its request for continued listing on the exchange.
June 20, 2024 | 8:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Invo Bioscience received a notice from Nasdaq granting its request for continued listing on the exchange. This is positive news as it ensures the company remains listed on a major exchange, which can help maintain investor confidence and liquidity.
The continued listing on Nasdaq is crucial for Invo Bioscience as it helps maintain investor confidence and liquidity. Being listed on a major exchange like Nasdaq is often seen as a sign of stability and credibility, which can positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100